The Invesco Dynamic Biotechnology & Genome ETF (PBE) is a fund designed to provide investors with exposure to the dynamic and rapidly evolving field of biotechnology and genome research. This ETF, managed by Invesco, seeks to replicate the performance of the ICE Data Biotechnology Index, a benchmark comprised of U.S. biotechnology and genome companies. These companies are at the forefront of biotechnological advancements, engaging in research, development, manufacturing, and the distribution of cutting-edge biotechnological products, services, and processes. As of June 30, 2023, the index consisted of 30 constituents with market capitalizations ranging from $876 million to $96 billion. PBE employs a full replication strategy to track the index, meaning it invests in all index components in proportion to their weightings. While the fund may concentrate its investments in the biotechnology and genome industry, it maintains the flexibility to adjust its holdings over time to adapt to evolving market dynamics.
While the Invesco Dynamic Biotechnology & Genome ETF (PBE) primarily focuses on tracking the performance of the biotechnology and genome industry, it may still provide dividend returns to investors. The dividend eligibility, distribution frequency, and policies of PBE are influenced by the individual dividend practices of the constituent companies within the biotechnology and genome sector. As of its last update in June 2023, PBE is comprised of 30 constituents, and its dividend distribution may fluctuate as these companies evolve and adapt within the biotechnology and genome field.
The Invesco Dynamic Biotechnology & Genome ETF (PBE) focuses on tracking the performance of the Biotechnology and Genome industry in the United States. This ETF invests at least 90% of its total assets in securities that make up the Underlying Index, which is curated by ICE Data Indices, LLC. The Underlying Index comprises common stocks of U.S. biotechnology and genome companies heavily involved in researching, developing, manufacturing, marketing, and distributing various biotechnological products, services, and processes. As of June 30, 2023, the Underlying Index consisted of 30 constituents, with market capitalizations ranging from $876 million to $96 billion. PBE utilizes a full replication approach, investing in all the securities within the Underlying Index in proportion to their weightings. The Fund may concentrate its investments in the biotechnology and genome industry, offering investors exposure to this innovative and rapidly evolving sector.
The correlation aspect of the Invesco Dynamic Biotechnology & Genome ETF (PBE) is fundamental in comprehending its performance in relation to the biotechnology and genome sector. Given that PBE tracks an index composed of U.S. biotechnology and genome companies, its correlation with this specific industry is expected to be significant. Understanding PBE's correlation with its underlying sector is crucial for investors looking to gain exposure to biotechnological advancements and genetic research. To analyze and delve deeper into PBE's correlations with other assets and sectors, investors can utilize our tool, ETF Insider, offering a user-friendly web app with insightful data visualization, thereby aiding in identifying potential overlaps and investment opportunities within the biotechnology and genome industry.
The Invesco Dynamic Biotechnology &Genome ETF (PBE) is predominantly involved in the biotechnology and genome industry. This sector focuses on companies engaged in research, development, manufacturing, marketing, and distribution of biotechnological products and services, benefitting from advancements in biotechnology and genetic engineering. PBE's portfolio includes biopharmaceutical firms, outsourced services providers, and companies offering scientific products for research and analysis. With a concentration in this innovative industry, PBE offers investors exposure to the potential growth and technological advancements within the biotech and genome sector.
The Invesco Dynamic Biotechnology &Genome ETF (PBE) focuses on providing exposure to the biotechnology and genome industry in the United States. This ETF aims to capture the growth potential of companies engaged in biotechnological research, development, manufacturing, marketing, and distribution of various biotechnological products and services. As of its last available data, the fund's portfolio comprised 30 constituents, ranging from small to large market capitalizations, reflecting its dedication to this specialized sector.
ETF Insider is a data-driven portfolio analytics and optimization platform that introduces a more efficient and practical way to visualize, analyze and optimize portfolios.
Rather than focusing on the surface-level attributes of ETFs and Mutual Funds, ETF Insider goes deeper by examining the underlying holdings of exchange traded products.
By organizing and structuring that data, investors can easily navigate within their overlapping layers.
This innovative perspective combined with modern data visualization and modeling tools, provides an entirely new approach to portfolio optimization that can quickly expose both portfolio inefficiencies and opportunities.
4 min readIBB VS pbe are specialized investment funds that focus on a diverse range of sectors in the financial market. these exchange-traded funds offer investors exposure to various industries and companies, presenting potential growth opportunities and risks. it's essential to understand the underlying assets and strategies of these etfs before considering an investment.
4 min readXBI VS pbe are specialized investment funds that focus on a diverse range of sectors in the financial market. these exchange-traded funds offer investors exposure to various industries and companies, presenting potential growth opportunities and risks. it's essential to understand the underlying assets and strategies of these etfs before considering an investment.
4 min readARKG & PBE are both ETFs that delve into the biotechnology & genomics sector. Understanding their tracking methods and exposure strategies aids investors.
ETF Insider is a novel portfolio optimization tool that uses the power of data visualization to gain insight into portfolio compositions, concentration risks, portfolio efficiency and more. Complex financial data can be transformed into visually appealing and easily digestible graphs and charts, allowing investors to quickly identify trends and make well-informed investment decisions. Not only does this save time, but it also increases the accuracy and effectiveness of portfolio management.
